Regina Kleinhans

Papers

Total Citations

H-Index

About

Regina Kleinhans is a pioneering figure in the development of sensor-based platforms for real-time monitoring of living cells and tissues, with a primary focus on advancing personalized cancer chemotherapy. Her most influential work centers on creating automated, non-invasive systems that enable continuous, controlled assays of cellular behavior, bridging the gap between traditional lab-based research and clinical application. In her landmark 2013 study, "Automated platform for sensor-based monitoring and controlled assays of living cells and tissues," which has garnered 26 citations, Kleinhans introduced a novel framework for integrating microsensors into cell culture environments, allowing for dynamic, high-resolution tracking of metabolic and morphological changes. This work laid the foundation for her 2012 paper, "Sensor-based cell and tissue screening for personalized cancer chemotherapy," cited 24 times, where she demonstrated how these platforms could be used to test chemotherapeutic agents on patient-derived tissues, offering a tailored approach to treatment selection. Her contributions are notable for their translational impact, providing oncologists with a powerful tool to optimize drug regimens and reduce adverse effects. Kleinhans’ research continues to inspire innovations in lab-on-a-chip technologies and precision medicine.